Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Mar. 15, 2024 | Jun. 30, 2023 | |
Document Information [Line Items] | |||
Entity, Registrant Name | CYCLO THERAPEUTICS, INC. | ||
Current Fiscal Year End Date | --12-31 | ||
Document, Fiscal Period Focus | FY | ||
Document, Fiscal Year Focus | 2023 | ||
Document, Type | 10-K/A | ||
Document, Annual Report | true | ||
Document, Period End Date | Dec. 31, 2023 | ||
Document, Transition Report | false | ||
Entity, File Number | 0-25466 | ||
Entity, Incorporation, State or Country Code | NV | ||
Entity, Tax Identification Number | 59-3029743 | ||
Entity, Address, Address Line One | 6714 NW 16th Street, Suite B, | ||
Entity, Address, City or Town | Gainesville | ||
Entity, Address, State or Province | FL | ||
Entity, Address, Postal Zip Code | 32653 | ||
City Area Code | 386 | ||
Local Phone Number | 418-8060 | ||
Entity, Well-known Seasoned Issuer | No | ||
Entity, Voluntary Filers | No | ||
Entity, Current Reporting Status | Yes | ||
Entity, Interactive Data, Current | Yes | ||
Entity, Filer Category | Non-accelerated Filer | ||
Entity, Small Business | true | ||
Entity, Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | false | ||
Document, Financial Statement Error Correction Flag | false | ||
Entity, Shell Company | false | ||
Entity, Public Float | $ 17,225,521 | ||
Entity, Common Stock Shares, Outstanding | 28,715,740 | ||
Auditor Name | WithumSmith+Brown, PC | ||
Auditor Location | East Brunswick, New Jersey | ||
Auditor Firm ID | 100 | ||
Amendment Description | The purpose of this Amendment No. 1 on Form 10-K/A (the “Amendment”) is to amend and restate Part III, Item 14 of the previously filed Annual Report on Form 10-K of Cyclo Therapeutics, Inc. (the “Company”) for the year ended December 31, 2023, filed with the Securities and Exchange Commission on March 18, 2024 (the “Original Form 10-K”), to include information previously omitted in reliance on General Instruction G to Form 10-K, which provides that registrants may incorporate by reference certain information from a definitive proxy statement prepared in connection with the election of directors. The Company has determined to include such Part III, Item 14 information by amendment of the Original Form 10-K rather than incorporation by reference to the proxy statement. Accordingly, Part III, Item 14 of the Original Form 10-K is hereby amended and restated as set forth below. This Amendment also includes the filing of new Exhibits 31.1 and 31.2. Except as described above, no other changes were made to the Original 10-K. | ||
Amendment Flag | true | ||
Entity, Central Index Key | 0000922247 | ||
CommonStockParValue0001PerShare Custom [Member] | |||
Document Information [Line Items] | |||
Title of 12(b) Security | Common Stock, par value $.0001 per share | ||
Trading Symbol | CYTH | ||
Security Exchange Name | NASDAQ | ||
WarrantsToPurchaseCommonStock Custom [Member] | |||
Document Information [Line Items] | |||
Title of 12(b) Security | Warrants to purchase Common Stock | ||
Trading Symbol | CYTHW | ||
Security Exchange Name | NASDAQ |